<unk>  is typically used for the treatment of high blood pressure, congestive heart failure, and diabetic nephropathy and after acute myocardial infarction (heart attack).<unk>  is part of the ACE Inhibitors drug class. Compared to other drugs within the same class such as Captopril and Enalapril,<unk>  has a longer duration of action of 24-36 hours. A review concluded that<unk>  was effective for treatment of proteinuric kidney disease, including diabetic proteinuria. In people of sub-Saharan African descent, calcium-channel blockers or thiazide diuretics may more effectively lower blood pressure than ACE inhibitors such as<unk> , although convincing evidence is lacking that these drugs differ in their effect on morbidity or mortality in such persons. Kidney problems In patients with moderate to severe kidney disease,<unk>  and other ACE Inhibitors are superior to Angiotensin II receptor blockers and other antihypertensive drugs for prevention of death, fatal cardiac events, and kidney injury. Dose reduction may be required when creatinine clearance is less than or equal to 30mL/min. Since<unk>  is removed by dialysis, dosing changes must also be considered for people on dialysis. Pregnancy and breastfeeding Animal and human data have revealed evidence of lethal harm to the embryo and teratogenicity associated with ACE inhibitors. No controlled data in human pregnancy are available. Birth defects have been associated with use of<unk>  in any trimester. Death and increased toxicity to the fetus and newly born child have been reported with the use of<unk>  in the second and third trimesters. The label states, "When pregnancy is detected, discontinue Zestril as soon as possible." The manufacturer recommends mothers should not breastfeed while taking this medication because of the current lack of safety data.
Lisinopril
Captopril
Azilsartan
Telmisartan
Losartan
Irbesartan
Valsartan
Nebivolol